- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/22 - Ribonucleases
Patent holdings for IPC class C12N 9/22
Total number of patents in this class: 14146
10-year publication summary
|
488
|
725
|
920
|
1171
|
1269
|
1406
|
1698
|
1954
|
1741
|
577
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20574 |
589 |
| The Broad Institute, Inc. | 1937 |
544 |
| Massachusetts Institute of Technology | 10208 |
480 |
| President and Fellows of Harvard College | 6045 |
476 |
| Pairwise Plants Services, Inc. | 288 |
176 |
| The General Hospital Corporation | 4827 |
171 |
| The Board of Trustees of the Leland Stanford Junior University | 6600 |
158 |
| Sangamo Therapeutics, Inc. | 384 |
154 |
| Editas Medicine, Inc. | 250 |
142 |
| Cellectis | 411 |
141 |
| Arbor Biotechnologies Inc. | 168 |
140 |
| CRISPR Therapeutics AG | 364 |
137 |
| Pioneer Hi-Bred International, Inc. | 6862 |
136 |
| Beam Therapeutics Inc. | 268 |
134 |
| Regeneron Pharmaceuticals, Inc. | 4618 |
132 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 278 |
126 |
| Duke University | 3166 |
124 |
| Novozymes A/S | 3346 |
121 |
| Precision Biosciences, Inc. | 201 |
120 |
| EmendoBio Inc. | 150 |
114 |
| Other owners | 9831 |